Tumor metastasis inhibiting compounds and methods
US5436221A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Feb 13, 1992 |
| Grant date | Jul 25, 1995 |
| Priority date | — |
| Expiry date | Feb 13, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G69/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A peptide derivative containing 1 to 20 units of peptide unit represented by the following general formula [I] or a pharmaceutically acceptable salt thereof; EQU [Z]--Arg--X--Asp--[Y] [I] wherein Arg represents L- or D-arginine residue, Asp represents L-aspartic acid residue, X represents L- or D-leucine, D-isoleucine, L- or D-norleucine, L- or D-phenylalanine, D-phenylglycine or D-alanine residue, and [Z] and [Y] each represents an amino acid or a peptide residue, which may be present or absent, selected from glycine, L-serine, L-threonine, L- and D-aspartic acid, L-alanine, L- and D-glutamic acid, L-proline residues and a peptide residue constituted by the foregoing amino acid residues, and a pharmaceutical composition comprising the peptide derivative. The composition of the present invention is useful as an agent for inhibiting tumor metastasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.